"CYP2C19 status and risk of major adverse cardiovascular events in peri" by J. Antonio Gutierrez, Gretchen M. Heizer et al.
 

CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial

Document Type

Letter to the Editor

Publication Date

11-1-2020

Journal

American Heart Journal

Volume

229

DOI

10.1016/j.ahj.2020.07.017

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 3
  • Usage
    • Abstract Views: 7
  • Captures
    • Readers: 18
see details

Share

COinS